Activation of the Aryl Hydrocarbon Receptor Dampens the Severity of Inflammatory Skin Conditions

Summary Environmental stimuli are known to contribute to psoriasis pathogenesis and that of other autoimmune diseases, but the mechanisms are largely unknown. Here we show that the aryl hydrocarbon receptor (AhR), a transcription factor that senses environmental stimuli, modulates pathology in psoriasis. AhR-activating ligands reduced inflammation in the lesional skin of psoriasis patients, whereas AhR antagonists increased inflammation. Similarly, AhR signaling via the endogenous ligand FICZ reduced the inflammatory response in the imiquimod-induced model of skin inflammation and AhR-deficient mice exhibited a substantial exacerbation of the disease, compared to AhR-sufficient controls. Nonhematopoietic cells, in particular keratinocytes, were responsible for this hyperinflammatory response, which involved upregulation of AP-1 family members of transcription factors. Thus, our data suggest a critical role for AhR in the regulation of inflammatory responses and open the possibility for novel therapeutic strategies in chronic inflammatory disorders.

[1]  L. Boon,et al.  Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice Is Mediated via the IL-23/IL-17 Axis1 , 2009, The Journal of Immunology.

[2]  J. Schalkwijk,et al.  Coal tar induces AHR-dependent skin barrier repair in atopic dermatitis. , 2013, The Journal of clinical investigation.

[3]  Luis Puig,et al.  Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions. , 2010, The Journal of investigative dermatology.

[4]  M. Suárez-Fariñas,et al.  A single intradermal injection of IFN-γ induces an inflammatory state in both non-lesional psoriatic and healthy skin , 2011, The Journal of investigative dermatology.

[5]  B. Becher,et al.  Rorγt+ innate lymphocytes and γδ T cells initiate psoriasiform plaque formation in mice. , 2012, The Journal of clinical investigation.

[6]  Terence P. Speed,et al.  A comparison of normalization methods for high density oligonucleotide array data based on variance and bias , 2003, Bioinform..

[7]  J. Krueger,et al.  Increased JunB mRNA and protein expression in psoriasis vulgaris lesions. , 2006, The Journal of investigative dermatology.

[8]  T. Zal,et al.  Body barrier surveillance by epidermal gammadelta TCR , 2012, Nature Immunology.

[9]  Chih‐Chung Lin,et al.  IL-1β Promotes Corneal Epithelial Cell Migration by Increasing MMP-9 Expression through NF-κB- and AP-1-Dependent Pathways , 2013, PloS one.

[10]  J. Hengstler,et al.  Aryl Hydrocarbon Receptor Is Critical for Homeostasis of Invariant γδ T Cells in the Murine Epidermis , 2011, The Journal of Immunology.

[11]  M. Széll,et al.  The psoriatic keratinocytes , 2012 .

[12]  C. Garlanda,et al.  AHR drives the development of gut ILC22 cells and postnatal lymphoid tissues via pathways dependent on and independent of Notch , 2011, Nature Immunology.

[13]  Andrew Johnston,et al.  Assessment of the psoriatic transcriptome in a large sample: additional regulated genes and comparisons with in vitro models. , 2010, The Journal of investigative dermatology.

[14]  H. Aburatani,et al.  Constitutive Expression of Aryl Hydrocarbon Receptor in Keratinocytes Causes Inflammatory Skin Lesions , 2005, Molecular and Cellular Biology.

[15]  Andrew Johnston,et al.  Dissecting the psoriasis transcriptome: inflammatory- and cytokine-driven gene expression in lesions from 163 patients , 2013, BMC Genomics.

[16]  T. Rabbitts,et al.  The LMO2 T-Cell Oncogene Is Activated via Chromosomal Translocations or Retroviral Insertion during Gene Therapy but Has No Mandatory Role in Normal T-Cell Development , 2003, Molecular and Cellular Biology.

[17]  F. Nestle,et al.  The IL-23/Th17 axis in the immunopathogenesis of psoriasis. , 2009, The Journal of investigative dermatology.

[18]  H. Glatt,et al.  The Suggested Physiologic Aryl Hydrocarbon Receptor Activator and Cytochrome P4501 Substrate 6-Formylindolo[3,2-b]carbazole Is Present in Humans* , 2009, Journal of Biological Chemistry.

[19]  Andrew Johnston,et al.  Genome-Wide Expression Profiling of Five Mouse Models Identifies Similarities and Differences with Human Psoriasis , 2011, PloS one.

[20]  L. Klotz,et al.  Lightening up the UV response by identification of the arylhydrocarbon receptor as a cytoplasmatic target for ultraviolet B radiation , 2007, Proceedings of the National Academy of Sciences.

[21]  A. Bowcock,et al.  Insights into psoriasis and other inflammatory diseases from large-scale gene expression studies. , 2001, Human molecular genetics.

[22]  Sun-Hee Kim,et al.  Novel Compound 2-Methyl-2H-pyrazole-3-carboxylic Acid (2-methyl-4-o-tolylazo-phenyl)-amide (CH-223191) Prevents 2,3,7,8-TCDD-Induced Toxicity by Antagonizing the Aryl Hydrocarbon Receptor , 2006, Molecular Pharmacology.

[23]  O. Boyman,et al.  Plasmacytoid predendritic cells initiate psoriasis through interferon-α production , 2005, The Journal of experimental medicine.

[24]  David A. Martin,et al.  The IL-23/T17 pathogenic axis in psoriasis is amplified by keratinocyte responses. , 2013, Trends in immunology.

[25]  Kazuya Masuda,et al.  Aryl hydrocarbon receptor negatively regulates dendritic cell immunogenicity via a kynurenine-dependent mechanism , 2010, Proceedings of the National Academy of Sciences.

[26]  E. Wagner,et al.  Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteins , 2005, Nature.

[27]  E. Zandi,et al.  AP-1 function and regulation. , 1997, Current opinion in cell biology.

[28]  S. Johnston,et al.  Transcription factor complex AP‐1 mediates inflammation initiated by Chlamydia pneumoniae infection , 2013, Cellular microbiology.

[29]  B. Reizis,et al.  Notch–RBP-J signaling controls the homeostasis of CD8− dendritic cells in the spleen , 2007, The Journal of experimental medicine.

[30]  James T. Elder,et al.  Identification of fifteen new psoriasis susceptibility loci highlights the role of innate immunity , 2012, Nature Genetics.

[31]  James T. Elder,et al.  Mouse models of psoriasis. , 2007, The Journal of investigative dermatology.

[32]  D. Botstein,et al.  Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[33]  M. E. Hahn,et al.  Unexpected diversity of aryl hydrocarbon receptors in non-mammalian vertebrates: insights from comparative genomics. , 2006, Journal of experimental zoology. Part A, Comparative experimental biology.

[34]  S. Werner,et al.  Aldara activates TLR7-independent immune defence , 2013, Nature Communications.

[35]  A. Hayday,et al.  Environmentally Responsive and Reversible Regulation of Epidermal Barrier Function by γδ T Cells , 2006 .

[36]  Guoying Liu,et al.  NetAffx: Affymetrix probesets and annotations , 2003, Nucleic Acids Res..

[37]  M. Veldhoen,et al.  Interleukin-17-producing gammadelta T cells selectively expand in response to pathogen products and environmental signals. , 2009, Immunity.

[38]  J. T. Wulu,et al.  Regression analysis of count data , 2002 .

[39]  H. Mukhtar,et al.  Ultraviolet-B exposure of human skin induces cytochromes P450 1A1 and 1B1. , 2000, The Journal of investigative dermatology.

[40]  C. Bradfield,et al.  The Aryl Hydrocarbon Receptor sans Xenobiotics: Endogenous Function in Genetic Model Systems , 2007, Molecular Pharmacology.

[41]  C. Elferink,et al.  Timing is everything: consequences of transient and sustained AhR activity. , 2009, Biochemical pharmacology.

[42]  Liang Zhou,et al.  The aryl hydrocarbon receptor regulates gut immunity through modulation of innate lymphoid cells. , 2012, Immunity.

[43]  Natalie A. Roberts,et al.  Exogenous Stimuli Maintain Intraepithelial Lymphocytes via Aryl Hydrocarbon Receptor Activation , 2011, Cell.

[44]  J. Reddy,et al.  Characterization of a murine Ahr null allele: involvement of the Ah receptor in hepatic growth and development. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[45]  J. Bartholomew,et al.  Aromatic hydrocarbon responsiveness-receptor agonists generated from indole-3-carbinol in vitro and in vivo: comparisons with 2,3,7,8-tetrachlorodibenzo-p-dioxin. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[46]  E. Hobeika,et al.  Natural Aryl Hydrocarbon Receptor Ligands Control Organogenesis of Intestinal Lymphoid Follicles , 2011, Science.

[47]  B. Stockinger,et al.  Differential Influences of the Aryl Hydrocarbon Receptor on Th17 Mediated Responses in vitro and in vivo , 2013, PloS one.

[48]  F. Nestle,et al.  The multitasking organ: recent insights into skin immune function. , 2011, Immunity.

[49]  A. Rannug,et al.  The aryl hydrocarbon receptor and light , 2006, Biological chemistry.

[50]  J. Gustafsson,et al.  Interactions of indoles with specific binding sites for 2,3,7,8-tetrachlorodibenzo-p-dioxin in rat liver. , 1985, Molecular pharmacology.

[51]  Suyan Tian,et al.  Meta-Analysis Derived (MAD) Transcriptome of Psoriasis Defines the “Core” Pathogenesis of Disease , 2012, PloS one.

[52]  J. Buer,et al.  The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins , 2008, Nature.

[53]  H. Tagami,et al.  Triggering factors. , 1997, Clinics in dermatology.

[54]  B. Becher,et al.  Langerinneg conventional dendritic cells produce IL-23 to drive psoriatic plaque formation in mice , 2013, Proceedings of the National Academy of Sciences.

[55]  Rainer Breitling,et al.  RankProd: a bioconductor package for detecting differentially expressed genes in meta-analysis , 2006, Bioinform..

[56]  W. Huber,et al.  which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. MAnorm: a robust model for quantitative comparison of ChIP-Seq data sets , 2011 .

[57]  Matti Pirinen,et al.  Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity , 2012 .

[58]  Frank O. Nestle,et al.  Mechanisms of Disease: Psoriasis. , 2009 .

[59]  K. Bock,et al.  Ah receptor: dioxin-mediated toxic responses as hints to deregulated physiologic functions. , 2006, Biochemical pharmacology.